CPT code 36470 denotes sclerotherapy involving injection of a sclerosing solution into a single vein, most often used to treat varicose veins and some vascular malformations (excluding telangiectasia). Nationally, this procedure is a common, minimally invasive option in vascular and phlebology care pathways and has implications for ambulatory care utilization and outpatient procedural billing.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context, typical sites of service, and the common payer landscape affecting coverage and claims processing. The publication summarizes national benchmarks where available, highlights relevant policy and coding considerations related to outpatient procedural billing, and outlines the clinical scenarios in which 36470 is applied.

This analysis is intended for billing professionals, practice managers, and clinicians seeking a concise reference on the clinical purpose and payer context of CPT code 36470. Data not provided in the input are noted as unavailable; the focus remains on clinical description, service setting, and the payers commonly involved in coverage and reimbursement decisions.